Blinatumomab

(Synonyms: bscCD19xCD3; AMG-103; MEDI-538; MT-103; BLINCYTO)
3 Cited Publications
고객리뷰

Based on 3 publication(s) in Google Scholar

Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity: 97.33%
  • CAS No.: 853426-35-4
  • 분자량:54.09 kDa
  • 보관:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • 순도&문서
  • References
  • Help & FAQs
Customer Validation & Images
Others
  • Others
100 mg

견적 받기 해외재고보유

Please select quantity
Amount: USD 0.00